Bengaluru company launches low-cost treatment for blood cancerImmuneel Therapeutics, co-founded by Kiran Mazumdar-Shaw, has introduced Qartemi, India's second CAR-T cell therapy, to treat B-cell Non-Ho...
Ajay Hinduja on advancing cancer care: Insights on CAR-T therapy innovationIndia has reached a milestone in cancer treatment with the first successful allogeneic CAR-T therapy at P. D. Hinduja Hospital, led by Dr. ...
India eases drug approval process, waives local trials for advanced therapiesIn a major policy shift, the Indian government has waived local clinical trial requirements for drugs and vaccines approved by major intern...
Laurus Labs shares rise over 4% as co acquires additional stake in lmmunoACTLaurus Labs is set to increase its stake in Immunoadoptive Cell Therapy (lmmunoACT) by 7.24% for $10.6m, taking its total stake in the comp...
Seeking technology, manufacturing partnership with Indian pharma companies, says Mexico foreign secretaryThe Mexican government has partnered with ImmunoAct, an IIT Bombay-incubated company which is developing cutting-edge chimeric antigen rece...
Immuneel's CAR-T cell therapy reports positive in early phase-2 trials in IndiaThe early results from the IMAGINE study were based on the first 10 patients of the planned 24 patients to be enrolled.Both adult and child...
Singer Ne-Yo's is 'serial cheater', claims wife Crystal RenayIn a tragic post on Instagram, American singer and songwriter Ne-Yo's wife accused the singer of cheating weeks after renewing their marria...
Excellgene partners with Bharat Biotech for variant proof Covid vaccineThe Coalition for Epidemic Preparedness Innovations has funded the partnership and will "provide up to USD 19.3 million in funding to devel...
Immuneel Therapeutics raises $15 million in fundingImmuneel Therapeutics is working on developing its own pipeline of chimeric antigen receptor T-cell (CAR-T) therapies and other cellular im...
Indian scientists claim to have designed vaccine against all variants of coronavirusWith new variants of the SARS-COV-2 virus triggering fresh waves of the highly infectious disease, scientists at the Kazi Nazrul University...
Cellogen to bring next-gen cancer therapy to India"Chimeric Antigen Receptor cells represent a cutting-edge technology that holds great promise for cancer treatment. We are delighted to off...
Laurus Labs acquires stake in IIT-Bombay incubated CAR-T cell therapy companyAs per the agreement, Laurus will acquire 26.62% stake (fully diluted basis) for a cash consideration of approximately Rs 46 crores, subjec...
Indegene acquires US-based Medical Marketing Economics for $10 millionIndegene raised $200 million from investment firms Carlyle and Brighton Park Capital in February and is looking at more acquisitions in the...
Gujarat polls: High Court rejects pleas against SEC order on reserved seatsOne of the petitioners from Tapi district, sought the high court's direction to quash the SEC's order dated September 9, 2020, reserving Ch...
Immuneel signs pact with Hospital Clínic de Barcelona to work on cancer therapyThe collaboration opens up opportunities for co-development of advanced assets to be deployed in Spain and India, said Immuneel in a press ...
Believe it or not: Mona Lisa's famed smile may be forcedMost neuropsychological theories say that if a smile is asymmetric it is usually non-genuine.
- Scientists develop new therapeutic antibody for dog cancers
Tokyo, Aug 26 (IANS) Japanese researchers have developed an antibody that induces immune responses, which significantly suppresses malignan...